References
1
Bergmeier SC.
Tetrahedron
2000,
56:
2561
2a
Reetz M.
Angew. Chem., Int. Ed. Engl.
1991,
30:
1531
2b
Ohfune Y.
Acc. Chem. Res.
1992,
25:
360
2c
Yokomatsu T.
Yuasa Y.
Shibuya S.
Heterocycles
1992,
33:
1051
2d
Golebiowski A.
Jurczak J.
Synlett
1993,
241
2e
Gante J.
Angew. Chem., Int. Ed. Engl.
1994,
33:
1699
3a
Umezawa H.
Aoyagi T.
Morishima H.
Matsuzaki M.
Hamada M.
Takeuchi T.
J. Antibiot.
1970,
23:
259
3b
Aoyagi T.
Tobe H.
Kojima F.
Hamada M.
Takeuchi T.
J. Antibiot.
1978,
31:
636
3c
Umezawa H.
Aoyagi T.
Suda H.
Hamada M.
Takeuchi T.
J. Antibiot.
1976,
29:
97
3d
Arcamone F.
Cassinelli G.
Orezzi P.
Franceschi G.
Mondelli R.
J. Am. Chem. Soc.
1964,
86:
5334
3e
Iwamoto RH.
Lim P.
Bhacca NS.
Tetrahedron Lett.
1968,
36:
3891
4a
Kim YH.
Acc. Chem. Res.
2001,
34:
955
4b
Annand NK.
Carreira EM.
J. Am. Chem. Soc.
2001,
123:
9687
4c
Corey EJ.
Helal CJ.
Angew. Chem. Int. Ed.
1998,
37:
1986
5
Chen YK.
Lurain AE.
Walsh PJ.
J. Am. Chem. Soc.
2002,
124:
12225 ; and references therein
6a
Ager DJ.
Prakash I.
Schaad DR.
Chem. Rev.
1996,
96:
835
6b
Larrow JF.
Schaus SE.
Jacobsen EN.
J. Am. Chem. Soc.
1996,
118:
7420
6c
Barret AGM.
Seefeld MA.
White AJP.
Williams DJ.
J. Org. Chem.
1996,
61:
2677
6d
Shibasaki M.
Sasai H.
Pure Appl. Chem.
1996,
68:
523
6e
DuBois J.
Tomooka CS.
Hong J.
Carreire EM.
J. Am. Chem. Soc.
1997,
119:
3179
6f
Bruncko M.
Schilingloff G.
Sharpless KB.
Angew. Chem., Int. Ed. Engl.
1997,
36:
1483
6g
Kobayashi S.
Ishitani H.
Ueno M.
J. Am. Chem. Soc.
1998,
120:
431
6h
Tomoyasu T.
Tomooka K.
Nakai T.
Synlett
1998,
1147
6i
Chung SK.
Lee JM.
Tetrahedron: Asymmetry
1999,
10:
1441
7a
Nugent WA.
J. Am. Chem. Soc.
1992,
114:
2768
7b
Enders D.
Jegelka U.
Ducker B.
Angew. Chem., Int. Ed. Engl.
1993,
32:
423
7c
Barret AGM.
Seefeld MA.
Tetrahedron
1993,
49:
7857
7d
Matsubara S.
Ukita H.
Kodama T.
Utimoto K.
Chem. Lett.
1994,
831
7e
Ligibe O.
Graffe B.
Sacquet MC.
Lhommet G.
Heterocycles
1994,
37:
1469
7f
Besse P.
Veschambre H.
Chenevert R.
Dickman M.
Tetrahedron: Asymmetry
1994,
5:
1727
8
Enders D.
Reinhold U.
Angew. Chem., Int. Ed. Engl.
1995,
34:
1219
9
Caron M.
Carlier PR.
Sharpless KB.
J. Org. Chem.
1985,
53:
5185
10
Wuts PG.
Pruitt LE.
Synthesis
1989,
622
11a
Li G.
Chang H.-T.
Sharpless KB.
Angew. Chem., Int. Ed. Engl.
1996,
35:
451
11b
Reiser O.
Angew. Chem., Int. Ed. Engl.
1996,
35:
1308
12a
Kobayashi S.
Ishitami H.
Ueno M.
J. Am. Chem. Soc.
1998,
120:
431
12b
Sigman MS.
Jacobsen EN.
J. Am. Chem. Soc.
1998,
120:
4901
13a
Tang TP.
Volkman SK.
Ellman JA.
J. Org. Chem.
2001,
66:
8772
13b
Ellman JA.
Owens TD.
Tang TP.
Acc. Chem. Res.
2002,
35:
984
14
Jung DY.
Ko C.
Kim YH.
Synlett
2004,
1315
15a
Boulineau FP.
Wei A.
Org. Lett.
2002,
4:
2281
15b
Boons GJPH.
Overhand M.
Van der Marel GA.
Van Boom JH.
Angew. Chem.
1989,
101:
1538
15c
Boons GJPH.
Van der Marel GA.
Van Boom JH.
Tetrahedron Lett.
1989,
30:
229
16a
Fleming I.
Sanderson PE.
Tetrahedron Lett.
1987,
28:
4229
16b
Tamao K.
Ishida N.
Tanaka T.
Kumada M.
Organometallics
1983,
2:
1694
16c
Tamao K.
Ishida N.
J. Organomet. Chem.
1984,
269:
C37
16d
Tamao K.
Kumada M.
Maeda K.
Tetrahedron Lett.
1984,
25:
321
17
Liu G.
Cogan DA.
Owens TD.
Tang TP.
Ellman JA.
J. Org. Chem.
1999,
64:
1278
18
Experimental Procedure for Preparation of [(Dimethyl-phenylsilyl)methyl] Magnesium Chloride (
1):
Under an argon atmosphere, a suspension of magnesium turnings (0.14 g, 5.83 mmol) in refluxing THF (2 mL) was activated by addition of catalytic amounts of 1,2-dibromo-ethane. Then,(chloromethyl)dimethylphenylsilane (902.1 µL, 5 mmol) was added at such a rate as to maintain a gentle reflux. After the addition was complete, the solution became transparent and grayish. To this solution, additional THF was added to adjust the concentration to be 0.5 M or 1.0 M and the mixture was refluxed for 2 h to give THF solutions of 1. The concentration of THF solution of 1 was determined by the method of Orgura et al.
[23]
19
Representative Experimental Procedure for the Addi-tion of 1 to tert
-Butanesulfinimines (Table 1, Entry 8):
tert-Butanesulfinimine 2a, prepared according to the known procedure,
[13]
was dissolved in THF and charged with argon. To this solution, [(dimethylphenylsilyl)methyl] magnesium chloride (0.5 M THF), prepared as above, was added dropwise and stirring was continued for 72 h. After TLC analysis indicated the completion of the reaction, the reaction mixture was diluted with Et2O and quenched with sat. NH4Cl aq solution. The organic layer was separated and the aqueous layer was further extracted with Et2O 3 times. The combined organic layer was dried over anhyd MgSO4 and the solvent was evaporated under reduced pressure. The crude product 3a was purified by flash column chromatography using EtOAc-n-hexane = 1:6 as eluents. The product was obtained in 75% yield. To determine diastereoselectivity, 3a was converted to 5a by procedures described below and analyzed with HPLC using racemic 5a, prepared independently as a standard. HPLC conditions: DAICEL AS-H column, 2-propanol-n-hexane = 1:99, 0.5 mL/min flow rate, retention time (major = 12.86 min, minor = 14.90 min). Determination of absolute configuration of major isomer was achieved by HPLC analysis of amino alcohol 6a using both S- and R-6a synthesized independently from the commercially available enantiopure phenyl glycine methyl ester [HPLC conditions: DAICEL OD-H column, 2-propanol-n-hexane = 5:95, 0.5 mL/min flow rate, t
R (R) = 15.72 min, t
R (S) = 18.99 min, synthetic 6a 15.81 min]. 1H NMR (300 MHz, CDCl3): δ =
-0.02 (s, 3 H), 0.15 (s, 3 H), 1.12 (s, 9 H), 1.42 (m, 2 H), 3.33 (s, 1 H), 4.52 (t, 1 H), 7.23 (m, 5 H), 7.31 (m, 3 H), 7.41 (m, 2 H). 13C NMR (75 MHz, CDCl3): δ = -3.440, -2.249, 22.457, 27.935, 55.172, 56.384, 127.408, 127.618, 128.002, 128.899, 129.190, 133.694, 138.259, 143.481. HRMS (EI): Anal. Calcd for C20H29NOSSi: 359.1739. Found: 359.1742.
20
Representative Experimental Procedure for Removal of Sulfinyl Group and Protection as Boc-carbamate (Preparation of 5b):
Compound 3b was dissolved in 1 mL of MeOH at 25 °C. To this solution, 1 mL of 1,4-dioxane and 1 mL of 4 M aq HCl solution was added. The resulting mixture was stirred for 1 h at that temperature. After TLC analysis indicated the complete consumption of 3b, the solvents and HCl were removed by evaporation under reduced pressure. The crude 4b was not purified and directly dissolved in mixed solvents of 1 mL of MeOH and 1 mL of Et3N, followed by addition of 1.5 equiv of (Boc)2O. After 1 h, the solvent was removed and the crude 5b was dissolved in CH2Cl2 and washed with Brine, sat. NH4Cl aq solution and brine successively. The resulting 5b was purified by column chromatography (eluent: EtOAc-n-hexane = 1:8) to give 5b in quantitative yield. 1H NMR (300 MHz, CDCl3): δ = 0.17 (s, 3 H), 0.22 (s, 3 H), 1.23 (m, 2 H), 1.25 (s, 9 H), 4.66 (m, 2 H), 7.05 (d, 2 H), 7.40 (m, 8 H). 13C NMR (75 MHz, CDCl3): δ = -3.100, -2.680, 25.430, 28.299, 51.864, 79.384, 120.666, 127.790, 127.849, 129.0182, 129.236, 131.430, 133.384, 144.214, 154.497. HRMS (EI): Anal. Calcd (433.1073) for C21H28BrNO2Si: C, 70.13; H, 8.24; N, 4.09; Si, 8.20; Br, 18.39. Found: 433.1124. HPLC (DAICEL AS-H column, 2-propanol-n-hexane = 1:99, 0.5 mL/min flow rate) t
R(minor) = 16.15 min, (major) = 20.22 min.
21
Representative Experimental Procedure for Fleming Oxidation (Table 3, Entry 1): HOAc (1 mL), NaOAc (0.032 g, 0.39 mmol), and KBr (0.045 g, 0.38 mmol) were added to 5a, and the mixture was stirred until the salts were dissolved. The solution was cooled to 0 °C and HOOAc (1.59 mL, 30% in HOAc) was added dropwise with exclusion of light. After the mixture was stirred for 3 h at 25 °C, TLC analysis indicated the completion of the reaction. The mixture was diluted with Et2O and poured into a cooled solution of Na2S2O3 (30 mL, 10%). The organic layer was washed with sat. aq solution of NaHCO3 until no more CO2 gas evolution was detected. The organic layer was dried over anhyd MgSO4 and the solvent was evaporated under reduced pressure. The resulting crude 5a was purified by column chromatography (eluent: EtOAc-n-hexane = 1:2). The spectral data of obtained 5a matched exactly with known compounds. 1H NMR (300 MHz, CDCl3): δ = 1.40 (s, 9 H), 2.39 (s, 1 H), 3.80 (m, 2 H), 4.74 (s, 1 H), 5.30 (s, 1 H), 7.32 (m, 5 H). 13C NMR (75 MHz, CDCl3): δ = 28.280, 57.079, 66,688, 79.902, 126.525, 127.632, 128.686, 139.621, 156.016.
22
HPLC Analysis of 3b-f and Determination of Absolute Configuration. HPLC Conditions:
Compound 3b: DAICEL AS-H column, 2-propanol-n-hexane = 1:99, 0.5 mL/min flow rate, t
R (R) = 14.08 min, t
R (S) = 17.44 min. Compound 3c: DAICEL AS-H column, 2-propanol-n-hexane = 1:99, 0.5 mL/min flow rate, t
R (R) = 19.89 min, t
R (S) = 23.11 min. Compound 3d: DAICEL
AS-H column, 2-propanol-n-hexane = 1:99, 0.5 mL/min flow rate, t
R (R) = 13.65 min, t
R (S) = 15.89 min. Compound 3e: DAICEL AS-H column, 2-propanol-n-hexane = 1:99, 0.5 mL/min flow rate, t
R (R) = 14.77 min, t
R (S) = 17.01 min. Compound 3f: DAICEL AS-H column, 2-propanol-n-hexane = 1:99, 0.5 mL/min flow rate, t
R (R) = 6.23 min, t
R (S) = 8.15 min. Determination of absolute configurations: 3b-f were tentatively assigned as (S
R
, R) in analogy with 3a.
[19]
The absolute stereochemistry of 3a-f and amino alcohols 6a-f were determined by comparisons with known compounds.
23
Aso Y.
Yamashita H.
Otsubo T.
Orgura F.
J. Org. Chem.
1989,
54:
5627